Cannabis
Freedom Cannabis Inc. Receives Cultivation and Medicinal Sales Licences from Health Canada
Freedom Cannabis Inc. (“Freedom” or the “Company”) is very pleased to announce it has received its licence to cultivate for Phase 1 of its indoor grow facility located near west Edmonton in Acheson, Alberta. The Company is also pleased to announce the concurrent receipt of its licence to sell cannabis for medical purposes.
“Receiving our cultivation licence and medicinal sales licence together is a major milestone for Freedom. The team is preparing to plant the first harvest in the coming weeks and will initially produce high quality flower and extracts in anticipation of servicing the demands of the medicinal and adult use cannabis markets in Canada and abroad” says Ed Bereznicki, Freedom’s Lead Advisor.
Freedom’s “commercial scale/craft quality” strategy utilizes smaller gardening areas and small batch cultivation techniques to mitigate risk and improve yields and quality. The Company believes this growing methodology, combined with its large and diverse genetics portfolio, will enable Freedom to offer a very impressive variety of high quality cannabis products.
With the successful licensing of Phase 1, Freedom expects to produce over 3,000 kilograms of dry cannabis per year. Freedom’s first harvest, including its compulsory test crops, is expected to occur in approximately 4 months.
Following the successful start-up of Phase 1, Freedom will continue with the buildout of Phase 2 of its 126,000 square foot (total) indoor grow facility. Located entirely within the existing building envelope, Phase 2 is expected to add an additional 12,000 kilograms per year of production capacity. In addition, construction of Freedom’s laboratory facilities will continue, including extraction, analytics and R&D.
Over the next few months, Freedom will continue adding to its talented team. In particular, individuals with quality assurance, gardening, operations, lab, packaging and marketing experience, among others, are invited to visit the Company’s website at www.freedomcannabis.ca to submit their interest.
Founded by Gianfranco Potestio, Troy Dezwart and Julie Girard-Potestio, Freedom is value driven and committed to a culture of sustainability, compassion and high standards.
SOURCE Freedom Cannabis
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan4 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf5 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care